Skip to main content
. 2020 Sep 8;2020(9):CD005291. doi: 10.1002/14651858.CD005291.pub3
# Query Results
S57 S44 AND S56 329
S56 S45 OR S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55 1,348,419
S55 TX allocat* random* 10,952
S54 (MH "Quantitative Studies") 23,227
S53 (MH "Placebos") 11,446
S52 TX placebo* 58,971
S51 TX random* allocat* 10,952
S50 (MH "Random Assignment") 56,376
S49 TX randomi* control* trial* 174,775
S48 TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) 1,030,939
S47 TX clinic* n1 trial* 250,159
S46 PT Clinical trial 86,851
S45 (MH "Clinical Trials+") 266,213
S44 S31 AND S43 2,527
S43 S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 42,195
S42 TX recurrent pregnancy loss* 659
S41 TX (advanced N2 age*) 4,923
S40 TX recurrent miscarriage* 557
S39 TX recurrent implantation failure* 249
S38 TX pregnancy fail* 7,850
S37 TX poor implantation* 922
S36 TX (ivf or ICSI) 4,828
S35 TX in vitro fertili?ation 6,852
S34 TX (embryo* or blastocyst* or blastomer*) 23,319
S33 TX intracytoplasmic sperm injection* 866
S32 (MM "Fertilization in Vitro") 3,354
S31 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 54,932
S30 TX (Pre implant* N3 test*) 202
S29 TX (Pre implant* N3 diagnos*) 121
S28 TX (Pre implant* N3 screen*) 50
S27 TX (spent culture medi*) 705
S26 TX (trophectoderm N3 biops*) 102
S25 TX (polar body N3 biops*) 8
S24 TX Next generation sequenc* 3,502
S23 TX WGA 101
S22 TX whole genome amplification* 154
S21 TX Nucleic Acid Amplification Technique* 1,436
S20 (MM "Nucleic Acid Amplification Techniques+") 3,510
S19 TX single nucleotide polymorphism 8,513
S18 (MM "Polymorphism, Genetic") 14,077
S17 Polymorphism, Single Nucleotide 8,444
S16 TX (qPCR or SNP) 9,861
S15 TX Quantitative Polymerase 7,315
S14 (MM "Polymerase Chain Reaction+") 3,016
S13 TX aCGH 174
S12 TX CGH 465
S11 TX (genom* N2 hybridi?ation) 667
S10 (MM "Nucleic Acid Hybridization") 83
S9 TX (gene* N2 screen*) 14,852
S8 TX (Preimplant* N2 screen*) 202
S7 TX Preimplant* Diagnos* 896
S6 (MM "In Situ Hybridization+") OR (MM "In Situ Hybridization, Fluorescence+") 450
S5 TX (PGS or PGD‐AS) 1,296
S4 TX aneuploid* 2,332
S3 TX (Preimplant* N3 gene*) 758
S2 (MM "Aneuploidy") 615
S1 (MM "Preimplantation Diagnosis") 500